Rochlitz C - Search Results

1

Current concepts of treatment strategies in advanced or recurrent ovarian cancer.

Salzberg M, Thurlimann B, Bonnefois H, Fink D, Rochlitz C, von Moos R, Senn H. Salzberg M, et al. Among authors: rochlitz c. Oncology. 2005;68(4-6):293-8. doi: 10.1159/000086967. Oncology. 2005. PMID: 16020955 Review.

2

Cancer gene and immunotherapy: recent developments.

Jantscheff P, Herrmann R, Rochlitz C. Jantscheff P, et al. Among authors: rochlitz c. Med Oncol. 1999 Jul;16(2):78-85. doi: 10.1007/BF02785840. Med Oncol. 1999. PMID: 10456655 Review.

3

Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer.

Biedermann B, Landmann C, Kann R, Passweg J, Solèr M, Lohri A, Rochlitz C, Herrmann R, Pless M. Biedermann B, et al. Among authors: rochlitz c. Radiother Oncol. 2000 Aug;56(2):169-73. doi: 10.1016/s0167-8140(00)00203-6. Radiother Oncol. 2000. PMID: 10927135

4

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer.

Rochlitz C, Figlin R, Squiban P, Salzberg M, Pless M, Herrmann R, Tartour E, Zhao Y, Bizouarne N, Baudin M, Acres B. Rochlitz C, et al. J Gene Med. 2003 Aug;5(8):690-9. doi: 10.1002/jgm.397. J Gene Med. 2003. PMID: 12898638 Clinical Trial.

5

Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.

Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, Micheel B, Brümmer J, Laffer U, Metzger U, Herrmann R, Rochlitz C. Jantscheff P, et al. Among authors: rochlitz c. J Clin Oncol. 2003 Oct 1;21(19):3638-46. doi: 10.1200/JCO.2003.55.135. J Clin Oncol. 2003. PMID: 14512395

6

Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial.

Thürlimann B, Hess D, Köberle D, Senn I, Ballabeni P, Pagani O, Perey L, Aebi S, Rochlitz C, Goldhirsch A. Thürlimann B, et al. Among authors: rochlitz c. Breast Cancer Res Treat. 2004 Jun;85(3):247-54. doi: 10.1023/B:BREA.0000025420.78346.f9. Breast Cancer Res Treat. 2004. PMID: 15111763 Clinical Trial.

7

Toxic encephalopathy induced by capecitabine.

Niemann B, Rochlitz C, Herrmann R, Pless M. Niemann B, et al. Among authors: rochlitz c. Oncology. 2004;66(4):331-5. doi: 10.1159/000078335. Oncology. 2004. PMID: 15218302

8

Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.

Uhlmann C, Ballabeni P, Rijken N, Brauchli P, Mingrone W, Rauch D, Pestalozzi BC, Rochlitz C, Aebi S; Swiss Group for Clinical Cancer Research; Swiss Institute for Applied Cancer Research. Uhlmann C, et al. Among authors: rochlitz c. Oncology. 2004;67(2):117-22. doi: 10.1159/000080997. Oncology. 2004. PMID: 15539915 Clinical Trial.

9

Prognostic and predictive relevance of microsatellite instability in colorectal cancer.

Storojeva I, Boulay JL, Heinimann K, Ballabeni P, Terracciano L, Laffer U, Mild G, Herrmann R, Rochlitz C. Storojeva I, et al. Among authors: rochlitz c. Oncol Rep. 2005 Jul;14(1):241-9. Oncol Rep. 2005. PMID: 15944796

10

Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer.

Storojeva I, Boulay JL, Ballabeni P, Buess M, Terracciano L, Laffer U, Mild G, Herrmann R, Rochlitz C. Storojeva I, et al. Among authors: rochlitz c. Oncology. 2005;68(2-3):246-55. doi: 10.1159/000086781. Epub 2005 Jul 7. Oncology. 2005. PMID: 16015041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters